Advertisement
Review Article| Volume 93, ISSUE 2, P519-531, April 2013

Miscellaneous Syndromes and Their Management

Occult Breast Cancer, Breast Cancer in Pregnancy, Male Breast Cancer, Surgery in Stage IV Disease
Published:February 11, 2013DOI:https://doi.org/10.1016/j.suc.2012.12.003

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Halsted W.S.
        The results of radical operation for the cure of carcinoma of the breast.
        Ann Surg. 1907; 46: 1-19
        • Baron P.L.
        • Moore M.P.
        • Kinne D.W.
        • et al.
        Occult breast cancer presenting with axillary metastases. Updated management.
        Arch Surg. 1990; 125: 210-214
        • Patel J.
        • Nemoto T.
        • Rosner D.
        • et al.
        Axillary lymph node metastasis from an occult breast cancer.
        Cancer. 1981; 47: 2923-2927
        • Copeland E.M.
        • McBride C.M.
        Axillary metastases from unknown primary sites.
        Ann Surg. 1973; 178: 25-27
        • Varadarajan R.
        • Edge S.B.
        • Yu J.
        • et al.
        Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis.
        Oncology. 2006; 71: 456-459
        • Abbruzzese J.L.
        • Abbruzzese M.C.
        • Hess K.R.
        • et al.
        Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients.
        J Clin Oncol. 1994; 12: 1272-1280
        • Hainsworth J.D.
        • Greco F.A.
        Management of patients with cancer of unknown primary site.
        Oncology (Williston Park). 2000; 14 ([discussion: 574–6, 578–9]): 563-574
        • Brill K.L.
        • Brenin D.R.
        Occult breast cancer and axillary mass.
        Curr Treat Options Oncol. 2001; 2: 149-155
        • Buchanan C.L.
        • Morris E.A.
        • Dorn P.L.
        • et al.
        Utility of breast magnetic resonance imaging in patients with occult primary breast cancer.
        Ann Surg Oncol. 2005; 12: 1045-1053
        • Cameron H.C.
        An address entitled some clinical facts regarding mammary cancer.
        Br Med J. 1909; 1: 577-582
        • Vilcoq J.R.
        • Calle R.
        • Ferme F.
        • et al.
        Conservative treatment of axillary adenopathy due to probable subclinical breast cancer.
        Arch Surg. 1982; 117: 1136-1138
        • Vlastos G.
        • Jean M.E.
        • Mirza A.N.
        • et al.
        Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases.
        Ann Surg Oncol. 2001; 8: 425-431
        • Abe H.
        • Naitoh H.
        • Umeda T.
        • et al.
        Occult breast cancer presenting axillary nodal metastasis: a case report.
        Jpn J Clin Oncol. 2000; 30: 185-187
        • Antonelli N.M.
        • Dotters D.J.
        • Katz V.L.
        • et al.
        Cancer in pregnancy: a review of the literature Part II.
        Obstet Gynecol Surv. 1996; 51: 135-142
        • Guidroz J.
        • Scott-Conner C.
        • Weigel R.
        Management of pregnant women with breast cancer.
        J Surg Oncol. 2011; 103: 337-340
        • Andersson T.M.
        • Johansson A.L.
        • Hsieh C.C.
        • et al.
        Increasing incidence of pregnancy-associated breast cancer in Sweden.
        Obstet Gynecol. 2009; 114: 568-572
        • Cardonick E.
        • Dougherty R.
        • Grana
        • et al.
        Breast cancer during pregnancy: maternal and fetal outcomes.
        Cancer J. 2010; 16: 76-82
        • Ishida T.
        • Yokoe T.
        • Kasumi F.
        • et al.
        Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan.
        Jpn J Cancer Res. 1992; 83: 1143-1149
        • Bunker M.L.
        • Peters M.V.
        Breast cancer associated with pregnancy or lactation.
        Am J Obstet Gynecol. 1963; 85: 312-321
        • Applewhite R.R.
        • Smith L.R.
        • DiVincenti F.
        Carcinoma of the breast associated with pregnancy and lactation.
        Am Surg. 1973; 39: 101-104
        • Tretli S.
        • Kvalheim G.
        • Thoresen S.
        • et al.
        Survival of breast cancer patients diagnosed during pregnancy or lactation.
        Br J Cancer. 1988; 58: 382-384
        • Navrozoglou I.
        • Vrekoussis T.
        • Kontostolis E.
        • et al.
        Breast cancer during pregnancy: a mini-review.
        Eur J Surg Oncol. 2008; 34: 837-843
        • Keleher A.J.
        • Theriault R.L.
        • Gwyn K.M.
        • et al.
        Multidisciplinary management of breast cancer concurrent with pregnancy.
        J Am Coll Surg. 2002; 194: 54-64
        • Nicklas A.H.
        • Baker M.E.
        Imaging strategies in the pregnant cancer patient.
        Semin Oncol. 2000; 27: 623-632
        • Mazonakis M.
        • Varveris H.
        • Damilakis J.
        • et al.
        Radiation dose to conceptus resulting from tangential breast irradiation.
        Int J Radiat Oncol Biol Phys. 2003; 55: 386-391
        • Novak Z.
        • Thurmond A.S.
        • Ross P.L.
        • et al.
        Gadolinium-DTPA transplacental transfer and distribution in fetal tissue in rabbits.
        Invest Radiol. 1993; 28: 828-830
        • Oyama T.
        • Koibuchi Y.
        • McKee G.
        Core needle biopsy (CNB) as a diagnostic method for breast lesions: comparison with fine needle aspiration cytology (FNA).
        Breast Cancer. 2004; 11: 339-342
        • Parente J.T.
        • Amsel M.
        • Lerner R.
        • et al.
        Breast cancer associated with pregnancy.
        Obstet Gynecol. 1988; 71: 861-864
        • Amant F.
        • Deckers S.
        • Van Calsteren K.
        • et al.
        Breast cancer in pregnancy: recommendations of an international consensus meeting.
        Eur J Cancer. 2010; 46: 3158-3168
        • Aziz S.
        • Pervez S.
        • Khan S.
        • et al.
        Case control study of novel prognostic markers and disease outcome in pregnancy/lactation-associated breast carcinoma.
        Pathol Res Pract. 2003; 199: 15-21
        • Scott-Conner C.E.
        • Schorr S.J.
        The diagnosis and management of breast problems during pregnancy and lactation.
        Am J Surg. 1995; 170: 401-405
        • Loibl S.
        • von Minckwitz G.
        • Gwyn K.
        • et al.
        Breast carcinoma during pregnancy. International recommendations from an expert meeting.
        Cancer. 2006; 106: 237-246
        • Gentilini O.
        • Cremonesi M.
        • Toesca A.
        • et al.
        Sentinel lymph node biopsy in pregnant patients with breast cancer.
        Eur J Nucl Med Mol Imaging. 2010; 37: 78-83
        • Gentilini O.
        • Cremonesi M.
        • Trifiro G.
        • et al.
        Safety of sentinel node biopsy in pregnant patients with breast cancer.
        Ann Oncol. 2004; 15: 1348-1351
        • Keleher A.
        • Wendt 3rd, R.
        • Delpassand E.
        • et al.
        The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid.
        Breast J. 2004; 10: 492-495
        • Jones A.L.
        Management of pregnancy-associated breast cancer.
        Breast. 2006; 15 Suppl 2: S47-S52
        • Dominici L.S.
        • Kuerer H.M.
        • Babiera G.
        • et al.
        Wound complications from surgery in pregnancy-associated breast cancer (PABC).
        Breast Dis. 2010; 31: 1-5
        • Whelan T.J.
        • Lada B.M.
        • Laukkanen E.
        • et al.
        Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
        Cancer Prev Control. 1997; 1: 228-240
        • Molckovsky A.
        • Madarnas Y.
        Breast cancer in pregnancy: a literature review.
        Breast Cancer Res Treat. 2008; 108: 333-338
        • Doll D.C.
        • Ringenberg Q.S.
        • Yarbro J.W.
        Antineoplastic agents and pregnancy.
        Semin Oncol. 1989; 16: 337-346
        • Zemlickis D.
        • Lishner M.
        • Degendorfer P.
        • et al.
        Fetal outcome after in utero exposure to cancer chemotherapy.
        Arch Intern Med. 1992; 152: 573-576
        • Azim Jr., H.A.
        • Azim H.
        • Peccatori F.A.
        Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge.
        Expert Rev Clin Immunol. 2010; 6: 821-826
        • Barthelmes L.
        • Gateley C.A.
        Tamoxifen and pregnancy.
        Breast. 2004; 13: 446-451
        • Isaacs R.J.
        • Hunter W.
        • Clark K.
        Tamoxifen as systemic treatment of advanced breast cancer during pregnancy—case report and literature review.
        Gynecol Oncol. 2001; 80: 405-408
      1. National Cancer Institute. Breast cancer. Available at: http://www.cancer.gov/cancertopics/types/breast. Accessed October 2012.

        • Jemel A.
        • Tiwari R.C.
        • Murray T.
        • et al.
        Cancer statistics, 2004.
        CA Cancer J Clin. 2004; 54: 8-29
        • Giordano S.H.
        • Cohen D.S.
        • Buzdar A.U.
        • et al.
        Breast carcinoma in men: a population based study.
        Cancer. 2004; 101: 51-57
        • Fentiman I.S.
        • Fourquet A.
        • Hortobagyi G.N.
        Male breast cancer.
        Lancet. 2006; 367: 595-604
        • Basham V.M.
        • Lipscombe J.M.
        • Ward J.M.
        • et al.
        BRCA 1 and BRCA 2 mutations in a population-based study of male breast cancer.
        Breast Cancer Res. 2002; 4: R2
        • Kwiatkowska E.
        • Teresiak M.
        • Filas V.
        • et al.
        BRCA 2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.
        Clin Cancer Res. 2003; 9: 4452-4459
        • Evans D.B.
        • Crichlow R.W.
        Carcinoma of the male breast and Klinefelter’s syndrome: is there an association?.
        CA Cancer J Clin. 1987; 37: 246-251
        • Thomas D.B.
        Breast cancer in men.
        Epidemiol Rev. 1993; 15: 220-231
        • Hultborn R.
        • Hanson C.
        • Kopf I.
        • et al.
        Prevalence of Klinefelter’s syndrome in male breast cancer patients.
        Anticancer Res. 1997; 17: 4293-4297
        • Giordano S.H.
        • Buzdar A.U.
        • Hortobagyi G.N.
        Breast cancer in men.
        Ann Intern Med. 2002; 137: 678-687
        • Thomas D.B.
        • Jimenez L.M.
        • McTiernan A.
        • et al.
        Breast cancer in men: risk factors with hormonal implications.
        Am J Epidemiol. 1992; 135: 734-748
        • Mabuchi K.
        • Bross D.S.
        • Kessler II,
        Risk factors for male breast cancer.
        J Natl Cancer Inst. 1985; 74: 371-375
        • Stalsberg H.
        • Thomas D.B.
        • Rosenblatt K.A.
        • et al.
        Histologic types and hormone receptors in male breast cancer in men: a population based study in 282 United States men.
        Cancer Causes Control. 1993; 4: 143-151
        • Ottini L.
        • Palli D.
        • Rizzo S.
        • et al.
        Male breast cancer.
        Crit Rev Oncol Hematol. 2010; 73: 141-155
        • Muir D.
        • Kanthan R.
        • Kanthan S.C.
        Male versus female breast cancers. A population based comparative immunohistochemical analysis.
        Arch Pathol Lab Med. 2003; 127: 36-41
        • Evans G.F.
        • Anthony T.
        • Turnage
        • et al.
        The diagnostic accuracy of mammography in the evaluation of male breast disease.
        Am J Surg. 2001; 181: 96-100
        • Contractor K.B.
        • Kaur K.
        • Rodrigues G.S.
        • et al.
        Male breast cancer: is the scenario changing.
        World J Surg Oncol. 2008; 6: 58
        • Hill A.D.
        • Borgen P.I.
        • Cody III, H.S.
        Sentinel node biopsy in male breast cancer.
        Eur J Surg Oncol. 1999; 25: 442-443
        • Flynn L.
        • Park J.
        • Patil S.
        Sentinel lymph node biopsy is successful and accurate in male breast carcinoma.
        J Am Coll Surg. 2008; 206: 616-621
        • Boughey J.C.
        • Bedrosian I.
        • Meric-Bernstam F.
        • et al.
        Comparative analysis of sentinel lymph node operation in male and female breast cancer patients.
        J Am Coll Surg. 2006; 203: 475-480
        • Giordano S.H.
        • Perkins G.H.
        • Broglio K.
        • et al.
        Adjuvant systemic therapy for male breast carcinoma.
        Cancer. 2005; 104: 2359-2364
        • Giordano S.H.
        A review of the diagnosis and management of male breast cancer.
        Oncologist. 2005; 10: 471-479
        • Lanitis S.
        • Rice A.J.
        • Vaughan A.
        • et al.
        Diagnosis and management of male breast cancer.
        World J Surg. 2008; 32: 2471-2476
        • Ribeiro G.
        • Swindell R.
        Adjuvant tamoxifen for male breast cancer (MBC).
        Br J Cancer. 1992; 65: 252-254
        • Yu E.
        • Suzuki H.
        • Younus J.
        • et al.
        The impact of post-mastectomy radiation therapy on male breast cancer patients—a case series.
        Int J Radiat Oncol Biol Phys. 2012; 82: 696-700
        • Ries L.
        • Melbert D.
        • Krapcho M.
        • et al.
        SEER cancer statistics review, 1975-2004.
        National Cancer Institute, 2007 (Available at:) (Accessed October 2012)
        • Andre F.
        • Slimane K.
        • Bachelot T.
        • et al.
        Breast cancer with synchronous metastases: trends in survival during a 14-year period.
        J Clin Oncol. 2004; 22: 3302-3308
        • Khan S.A.
        • Stewart A.K.
        • Morrow M.
        Does aggressive local therapy improve survival in metastatic breast cancer?.
        Surgery. 2002; 132: 620-626
        • Gnerlich J.
        • Jeffe D.B.
        • Deshpande A.D.
        • et al.
        Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data.
        Ann Surg Oncol. 2007; 14: 2187-2194
        • Babiera G.V.
        • Rao R.
        • Feng L.
        • et al.
        Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
        Ann Surg Oncol. 2006; 13: 776-782
        • Cady B.
        • Nathan N.R.
        • Michaelson J.S.
        • et al.
        Matched pair analyses of stage IV breast cancer with or without resection of primary breast site.
        Ann Surg Oncol. 2008; 15: 3384-3395
        • Bafford A.C.
        • Burstein H.J.
        • Barkley C.R.
        • et al.
        Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.
        Breast Cancer Res Treat. 2009; 115: 7-12
        • Neuman H.B.
        • Morrogh M.
        • Gonen M.
        • et al.
        Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter?.
        Cancer. 2010; 116: 1226-1233